FINWIRES · TerminalLIVE
FINWIRES

Amrize's Q2 Earnings Miss, EBITDA Guidance Cut Raise Execution Concerns, RBC Capital Markets Says

By

Amrize's (AMRZ) Q2 earnings miss and reduced full-year adjusted EBITDA guidance showed weaker execution than its major peers and raised concerns about the company's ability to convert higher volumes into stronger profits, RBC Capital Markets said in a note Monday.

The investment firm said Amrize was the only "major heavyside" building-materials company to miss Q2 earnings estimates and cut full-year earnings before interest, taxes, depreciation, and amortization guidance, while its competitors beat expectations and maintained their outlooks.

Although Amrize has a well invested cement plant network, scale advantages and opportunities from vertical integration, rising volumes have not translated into higher profits, the firm said. Management has said that margins were affected by timing differences between cost increases and offsetting surcharges or price increases, according to the note.

The firm cut its EBITDA estimates for 2026 through 2028 by 4%, 6% and 7%, respectively, and reduced EPS estimates by 12%, 14% and 15%.

RBC downgraded Amrize to underperform from sector perform, and cut the price target to $48 from $60.

Price: $46.49, Change: $-0.15, Percent Change: -0.32%

Related Articles

Wire

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS